TG THERAPEUTICS, INC. (TGTX) Operating cash flow 2016–2025
TG THERAPEUTICS, INC. (TGTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.8MFY2025 · since FY2016: -$61.6M → -$24.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.8M | +38.9% |
| FY2024 | -$40.5M | -29.0% |
| FY2023 | -$31.4M | +82.2% |
| FY2022 | -$176.2M | +40.4% |
| FY2021 | -$295.6M | -37.8% |
| FY2020 | -$214.5M | -61.5% |
| FY2019 | -$132.8M | -3.0% |
| FY2018 | -$128.9M | -37.5% |
| FY2017 | -$93.8M | -52.2% |
| FY2016 | -$61.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TGTX financial trends
TGTX RevenueTGTX Net incomeTGTX Net marginTGTX Gross profitTGTX Gross marginTGTX Operating incomeTGTX Operating marginTGTX Free cash flowTGTX Capital expendituresTGTX Return on equityTGTX Stock buybacksTGTX Dividends paidTGTX Total assetsTGTX Total liabilitiesTGTX Shareholders’ equityTGTX overview →